Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Neutral glycosphingolipids [SP05]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMSP0505AM08 type II H antigen(d18:1/26:1(17Z)) Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Hex(4)-HexNAc(2)-Fuc-Cer 44:2;O2 C90H161N3O37 1876.080904
LMSP0505AN01 Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Hex(4)-HexNAc(3)-Cer 34:1;O2 C82H146N4O38 1794.961518
LMSP0505AN02 Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Hex(4)-HexNAc(3)-Cer 36:1;O2 C84H150N4O38 1822.992818
LMSP0505AN03 Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Hex(4)-HexNAc(3)-Cer 38:1;O2 C86H154N4O38 1851.024118
LMSP0505AN04 Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Hex(4)-HexNAc(3)-Cer 40:1;O2 C88H158N4O38 1879.055418
LMSP0505AN05 Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Hex(4)-HexNAc(3)-Cer 42:1;O2 C90H162N4O38 1907.086718
LMSP0505AN06 Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Hex(4)-HexNAc(3)-Cer 44:1;O2 C92H166N4O38 1935.118018
LMSP0505AN07 Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Hex(4)-HexNAc(3)-Cer 42:2;O2 C90H160N4O38 1905.071068
LMSP0505AN08 Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Hex(4)-HexNAc(3)-Cer 44:2;O2 C92H164N4O38 1933.102368
LMSP0505AO01 type II B antigen(d18:1/16:0) Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Hex(5)-HexNAc(2)-Fuc-Cer 34:1;O2 C86H153N3O42 1899.992879
LMSP0505AO02 type II B antigen(d18:1/18:0) Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Hex(5)-HexNAc(2)-Fuc-Cer 36:1;O2 C88H157N3O42 1928.024179
LMSP0505AO03 type II B antigen(d18:1/20:0) Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Hex(5)-HexNAc(2)-Fuc-Cer 38:1;O2 C90H161N3O42 1956.055479
LMSP0505AO04 type II B antigen(d18:1/22:0) Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Hex(5)-HexNAc(2)-Fuc-Cer 40:1;O2 C92H165N3O42 1984.086779
LMSP0505AO05 type II B antigen(d18:1/24:0) Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Hex(5)-HexNAc(2)-Fuc-Cer 42:1;O2 C94H169N3O42 2012.118079
LMSP0505AO06 type II B antigen(d18:1/26:0) Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Hex(5)-HexNAc(2)-Fuc-Cer 44:1;O2 C96H173N3O42 2040.149379
LMSP0505AO07 type II B antigen(d18:1/24:1(15Z)) Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Hex(5)-HexNAc(2)-Fuc-Cer 42:2;O2 C94H167N3O42 2010.102429
LMSP0505AO08 type II B antigen(d18:1/26:1(17Z)) Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Hex(5)-HexNAc(2)-Fuc-Cer 44:2;O2 C96H171N3O42 2038.133729
LMSP0505AP01 I antigen(d18:1/16:0) Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Hex(5)-HexNAc(3)-Cer 34:1;O2 C88H156N4O43 1957.014343
LMSP0505AP02 I antigen(d18:1/18:0) Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Hex(5)-HexNAc(3)-Cer 36:1;O2 C90H160N4O43 1985.045643
LMSP0505AP03 I antigen(d18:1/20:0) Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Hex(5)-HexNAc(3)-Cer 38:1;O2 C92H164N4O43 2013.076943
LMSP0505AP04 I antigen(d18:1/22:0) Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Hex(5)-HexNAc(3)-Cer 40:1;O2 C94H168N4O43 2041.108243
LMSP0505AP05 I antigen(d18:1/24:0) Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Hex(5)-HexNAc(3)-Cer 42:1;O2 C96H172N4O43 2069.139543
LMSP0505AP06 I antigen(d18:1/26:0) Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Hex(5)-HexNAc(3)-Cer 44:1;O2 C98H176N4O43 2097.170843
LMSP0505AP07 I antigen(d18:1/24:1(15Z)) Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Hex(5)-HexNAc(3)-Cer 42:2;O2 C96H170N4O43 2067.123893
LMSP0505AP08 I antigen(d18:1/26:1(17Z)) Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Hex(5)-HexNAc(3)-Cer 44:2;O2 C98H174N4O43 2095.155193
LMSP0505AQ01 type II A antigen(d18:1/16:0) GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Hex(4)-HexNAc(3)-Fuc-Cer 34:1;O2 C88H156N4O42 1941.019428
LMSP0505AQ02 type II A antigen(d18:1/18:0) GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Hex(4)-HexNAc(3)-Fuc-Cer 36:1;O2 C90H160N4O42 1969.050728
LMSP0505AQ03 type II A antigen(d18:1/20:0) GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Hex(4)-HexNAc(3)-Fuc-Cer 38:1;O2 C92H164N4O42 1997.082028
LMSP0505AQ04 type II A antigen(d18:1/22:0) GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Hex(4)-HexNAc(3)-Fuc-Cer 40:1;O2 C94H168N4O42 2025.113328
LMSP0505AQ05 type II A antigen(d18:1/24:0) GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Hex(4)-HexNAc(3)-Fuc-Cer 42:1;O2 C96H172N4O42 2053.144628
LMSP0505AQ06 type II A antigen(d18:1/26:0) GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Hex(4)-HexNAc(3)-Fuc-Cer 44:1;O2 C98H176N4O42 2081.175928
LMSP0505AQ07 type II A antigen(d18:1/24:1(15Z)) GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Hex(4)-HexNAc(3)-Fuc-Cer 42:2;O2 C96H170N4O42 2051.128978
LMSP0505AQ08 type II A antigen(d18:1/26:1(17Z)) GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Hex(4)-HexNAc(3)-Fuc-Cer 44:2;O2 C98H174N4O42 2079.160278
LMSP0505AR01 Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Hex(5)-HexNAc(3)-Fuc(2)-Cer 34:1;O2 C100H176N4O51 2249.130163
LMSP0505AR02 Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Hex(5)-HexNAc(3)-Fuc(2)-Cer 36:1;O2 C102H180N4O51 2277.161463
LMSP0505AR03 Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Hex(5)-HexNAc(3)-Fuc(2)-Cer 38:1;O2 C104H184N4O51 2305.192763
LMSP0505AR04 Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Hex(5)-HexNAc(3)-Fuc(2)-Cer 40:1;O2 C106H188N4O51 2333.224063
LMSP0505AR05 Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Hex(5)-HexNAc(3)-Fuc(2)-Cer 42:1;O2 C108H192N4O51 2361.255363
LMSP0505AR06 Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Hex(5)-HexNAc(3)-Fuc(2)-Cer 44:1;O2 C110H196N4O51 2389.286664
LMSP0505AR07 Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Hex(5)-HexNAc(3)-Fuc(2)-Cer 42:2;O2 C108H190N4O51 2359.239713
LMSP0505AR08 Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Hex(5)-HexNAc(3)-Fuc(2)-Cer 44:2;O2 C110H194N4O51 2387.271013
LMSP0505AS01 Lex-7(d18:1/16:0) Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Hex(4)-HexNAc(2)-Fuc-Cer 34:1;O2 C80H143N3O37 1737.940054
LMSP0505AS02 Lex-7(d18:1/18:0) Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Hex(4)-HexNAc(2)-Fuc-Cer 36:1;O2 C82H147N3O37 1765.971354
LMSP0505AS03 Lex-7(d18:1/20:0) Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Hex(4)-HexNAc(2)-Fuc-Cer 38:1;O2 C84H151N3O37 1794.002654
LMSP0505AS04 Lex-7(d18:1/22:0) Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Hex(4)-HexNAc(2)-Fuc-Cer 40:1;O2 C86H155N3O37 1822.033954
LMSP0505AS05 Lex-7(d18:1/24:0) Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Hex(4)-HexNAc(2)-Fuc-Cer 42:1;O2 C88H159N3O37 1850.065254
LMSP0505AS06 Lex-7(d18:1/26:0) Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Hex(4)-HexNAc(2)-Fuc-Cer 44:1;O2 C90H163N3O37 1878.096554
LMSP0505AS07 Lex-7(d18:1/24:1(15Z)) Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Hex(4)-HexNAc(2)-Fuc-Cer 42:2;O2 C88H157N3O37 1848.049604
LMSP0505AS08 Lex-7(d18:1/26:1(17Z)) Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Hex(4)-HexNAc(2)-Fuc-Cer 44:2;O2 C90H161N3O37 1876.080904
LMSP0505AT01 Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Hex(7)-HexNAc(3)-Fuc(2)-Cer 34:1;O2 C112H196N4O61 2573.235814